For October 2016 we have selected: Sevigny J, Chiao P, Bussiere T, et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature 2016;537:50-56. Alzheimer’s disease (AD) is the most frequent neurodegenerative disorder. It is also extremely disabling with severe impact of the quality of life of patients and caregivers. The main pathological process is related to the toxic deposition of amyloid-β plaques and neurofibrillary tangles. No effective treatment is currently available to slow down the disease progression.

EANpages has the honor and the pleasure to introduce this virtual Round Table, composed by some members of the EAN Scientific Panel on Dementia and Cognitive Disorders, who are discussing the Paper of the Month, in addition to the comments of the Presidential Page. We thank the Panel for their enthusiastic participation and we invite all EAN members to participate with sending their comments.

David B. Vodušek (DV): EFNS has been a founding member of EBC, and its successor EAN continues to be an actively involved member society. Nevertheless, many of our readers would appreciate to hear your views on what is EBC, its mission and how it gets this accomplished? David Nutt (DN): The ultimate reason behind all EBC actions is to improve the condition of those living with brain disorders and to reduce prevalence of brain diseases all together.

By Jose E. Martínez-Rodríguez
More than 9000 participants attended the 32nd Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS) and the 21st Annual Conference of Rehabilitation in MS in London from September 14th to17th.… Continue Reading

Cruccu G, Garcia-Larrea L, Hansson P, Keindl M, Lefaucheur JP, Paulus W, Taylor R, Tronnier V, Truini A, Attal N. EAN guidelines on central neurostimulation therapy in chronic pain conditions. Eur J Neurol. 2016 Aug 11. Why these guidelines ?… Continue Reading

Georgia (Georgian: საქართველო, Sakartvelo) is a country located at the intersection of Eastern Europe and West Asia, and generally considered to be part of the European continent. To the west it is bordered by the Black Sea, to the north and northeast by Russia, to the south by Turkey and Armenia, and by Azerbaijan to the southeast.

For September 2016 we have selected: Mattle HP, Evers S, Hildick-Smith D, et al. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. Eur Heart J 2016:37;2029-2036. There are about 50 million people suffering from migraine in Europe. About one third of the cases has migraine with aura, that has been found more prevalent in patients with patent foramen ovale (PFO).

David Vodušek (DV): The AFAN, like the EAN, addresses and covers the neurological interest of a continent. Can you explain to the readers of the EANpages how was the AFAN created and why? Mansour Ndiaye (MN): Delegates from over 30 countries in Africa representing the interests of their national neurologic societies and associations met in Dakar, Senegal, over the weekend of August 29-30, 2015.

Video: Voices of the Congress – 2nd EAN Congress Copenhagen 2016 was last modified: August 31st, 2016 by Editor… Continue Reading

About us
The French Association of Residents & Young Neurologists, ANAINF (Association des assistants et internes de neurologie de France), was born in 1997 in order to represent, inform, and advise the young neurologists during their residency (DES) in neurology… Continue Reading